YL-15293

N/A

Report date: 2023/03/21 14:06:26
NME

Base Information

Drug NameYL-15293
Drug Alias NameYL-15293YL15293
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKRAS G12C inhibitors
TargetsKRAS G12C
Therapy Area/IndicationsSolid tumoursLung NeoplasmsPancreatic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesYL-Pharma
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesYL-Pharma
Inactive CompaniesN/A
Active IndicationsSolid tumoursLung NeoplasmsPancreatic Neoplasms +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A